Drug Shortage Report for ACT PROGESTERONE INJECTION

Last updated on 2020-03-05 History
Report ID 97147
Drug Identification Number 02446820
Brand name ACT PROGESTERONE INJECTION
Common or Proper name PROGESTERONE 500MG/10ML INJ
Company Name ACTAVIS PHARMA COMPANY
Active Ingredient(s) PROGESTERONE
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 1
ATC code G03DA
ATC description PROGESTOGENS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-23
Estimated end date 2020-04-30
Actual end date
Shortage status Actual shortage
Updated date 2020-03-05
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-03-05 French Compare
v3 2020-03-05 English Compare
v2 2019-10-24 French Compare
v1 2019-10-24 English Compare